NVO Congressional Stock Trades
Novo Nordisk A/S
Last disclosed trade Aug 26
Every disclosed trade in NVO by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every healthcare stock Congress trades.
Sample · the intelligence layer
Marjorie Taylor Greene · Bought $NVO · Aug 19 · $15K–$50K
1 other member traded this name in the same window.
Coldpine’s read
Greene's purchase of Novo Nordisk, maker of GLP-1 drugs Ozempic and Wegovy, was disclosed within one day, a fast turnaround that means the market may not have absorbed the filing. At least one other member traded the same name in the same direction within 30 days, indicating some cluster activity. The $15,001–$50,000 range is consistent with her typical individual equity purchases.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $NVO
Get notified when any member of Congress trades $NVO. Free, no card, no spam.
The record on $NVO
Coldpine has parsed 39 disclosed trades in $NVO by 8 members of Congress, drawn from 22 periodic transaction reports dated Oct 7, 2022 through Aug 26, 2026. That is 38 trades from House members and 1 trade from senators, filed 10 by Democrats and 29 by Republicans.
Of the 39 trades with a known filing lag, 3 were reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 22 days. The longest was 763 days: a $NVO purchase by Byron Donalds dated Oct 7, 2022, disclosed Nov 8, 2024. How late filing is measured across all of Congress is in the late-filers study.
31 of the 36 trades that list an account holder (86%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Michael T. McCaul filed the most $NVO purchases (10), and Rohit Khanna the most sales (6).
Activity peaked in 2024 with 15 trades. The busiest single month was August 2025, when 2 different members disclosed $NVO trades.
Across the 26 purchases Coldpine can price, $NVO moved +1.08% on average between the trade date and the disclosure date, against +2.00% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 50% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.
Members who trade NVO
Recent disclosed trades in NVO
| Date | Member | Type | Amount |
|---|---|---|---|
| Aug 26 | Scott Franklin(FL) | buy | $1K–$15K |
| Mar 30 | Alan Armstrong(OK) | buy | $15K–$50K |
| Oct 15 | Marjorie Taylor Greene(GA) | buy | $1K–$15K |
| Sep 11 | Lisa McClain(MI) | buy | $1K–$15K |
| Aug 28 | Marjorie Taylor Greene(GA) | buy | $1K–$15K |
| Aug 19 | Marjorie Taylor Greene(GA) | buy | $15K–$50K |
| Aug 4 | Scott Franklin(FL) | buy | $1K–$15K |
| Aug 4 | Scott Franklin(FL) | buy | $1K–$15K |
| Aug 4 | Scott Franklin(FL) | buy | $1K–$15K |
| Aug 4 | Scott Franklin(FL) | buy | $15K–$50K |
| May 8 | Laurel Lee(FL) | sell | $1K–$15K |
| Mar 27 | Scott Franklin(FL) | buy | $15K–$50K |
| Mar 27 | Scott Franklin(FL) | buy | $1K–$15K |
| Mar 20 | Byron Donalds(FL) | sell | $1K–$15K |
| Mar 20 | Byron Donalds(FL) | sell | $1K–$15K |
| Dec 23 | Michael T. McCaul(TX) | buy | $15K–$50K |
| Dec 23 | Michael T. McCaul(TX) | buy | $15K–$50K |
| Oct 31 | Michael T. McCaul(TX) | buy | $15K–$50K |
| Oct 31 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Aug 26 | Michael T. McCaul(TX) | sell | $1K–$15K |
Showing 20 of 39 disclosed trades.
Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).
Create a free accountFrom Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →